Large differences in patterns of breast cancer survival between Australia and England: A comparative study using cancer registry data

Authors

  • Laura M. Woods,

    Corresponding author
    1. Cancer Research UK Survival Group, Non-Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom
    • Cancer Research UK Survival Group, Non-Communicable Disease Epidemiology Unit, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom
    Search for more papers by this author
    • Fax: +44-20-7436-4230.

  • Bernard Rachet,

    1. Cancer Research UK Survival Group, Non-Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom
    Search for more papers by this author
  • Dianne O'Connell,

    1. Cancer Epidemiology Research Unit, Cancer Research Division, The Cancer Council NSW, Kings Cross, New South Wales, Australia
    Search for more papers by this author
  • Gill Lawrence,

    1. West Midlands Cancer Intelligence Unit, Public Health Building, University of Birmingham, Birmingham, United Kingdom
    Search for more papers by this author
  • Elizabeth Tracey,

    1. New South Wales Central Cancer Registry, The Cancer Institute, Alexandria, New South Wales, Australia
    Search for more papers by this author
  • Alan Willmore,

    1. Centre for Epidemiology and Research, NSW Department of Health, North Sydney, New South Wales, Australia
    Search for more papers by this author
  • Michel P. Coleman

    1. Cancer Research UK Survival Group, Non-Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom
    Search for more papers by this author

Abstract

Survival from breast cancer in the UK is lower than in other countries in Western Europe, the USA and Australia. However, these international differences have not yet been examined in relation to tumor characteristics, treatment, screening history or other prognostic factors. We calculated relative survival by age, period of diagnosis, category of unemployment and extent of disease for women diagnosed with breast cancer during the period 1980–2002 in New South Wales (Australia) and West Midlands (England). National cancer registry data for each country for the period 1990–1994 were also examined. The excess hazard ratio was modeled as a function of prognostic covariables. Survival in Australia and New South Wales was higher than in England and West Midlands, respectively. In both regions, survival was lower for more deprived women and for the elderly. These differences were greater in West Midlands. Survival from localized and regional disease in New South Wales was higher than in West Midlands, but survival from metastatic disease was similar. Differences in breast cancer survival are unlikely to be entirely due to differences in data quality or to limitations of the analyses, although the measure of extent of disease used may not have been adequate to elucidate the effect of stage fully. One possible causal explanation is that the management of breast cancer differs between these regions. Further research should acquire better data on stage and investigate the effect of comorbidity and of patterns of care upon the difference in breast cancer survival between England and Australia. © 2008 Wiley-Liss, Inc.

Ancillary